Monday, October 8, 2018
- 1:15pm-2:45pm
-
Profiles of microRNA in cerebrospinal fluid could be potential biomarkers for identifying motor subtype of Parkinson’s disease
Parkinson's Disease: Pathophysiology · Hall 3FG
- 1:15pm-2:45pm
-
Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study
Parkinson's Disease: Non-Motor Symptoms · Hall 3FG
- 1:15pm-2:45pm
-
Properties of oscillatory neuronal activity in the basal ganglia and thalamus in patients with Parkinson’s disease
Parkinson's Disease: Pathophysiology · Hall 3FG
- 1:15pm-2:45pm
-
Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease
- 1:15pm-2:45pm
-
Protective effects of Mucuna pruriens seed on rat brain: A therapeutic potential drug for Parkinson’s disease
Parkinson's Disease: Pathophysiology · Hall 3FG
- 1:15pm-2:45pm
-
Proteomic analysis of tear-fluid reveals disease-specific patterns in patients with Parkinson’s Disease
Parkinson's Disease: Non-Motor Symptoms · Hall 3FG
- 1:15pm-2:45pm
-
PrP as a receptor of alpha-synuclein in the pancreas of patients with synucleinopathies
Parkinson's Disease: Pathophysiology · Hall 3FG
- 1:15pm-2:45pm
-
PTRHD1 loss-of-function mutation in an African family with parkinsonism and intellectual disability
Parkinson's Disease: Genetics · Hall 3FG
- 1:15pm-2:45pm
-
Pupil evaluation as the test for the clinical manifestations of Parkinson’s disease
Parkinson's Disease: Pathophysiology · Hall 3FG
- 1:15pm-2:45pm
-
Putaminal dopamine depletion in de novo Parkinson’s disease predicts future development of wearing-off
- «Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 59
- Next Page»